- 8.10.2024
- News
VETS Stands Firm: Our Response to the FDA's Decision on MDMA-Assisted Therapy
Today, the Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) to Lykos Therapeutics in response to their application for approval of MDMA-assisted therapy.
- 8.8.2024
- News
The New York Times: Veterans and Lawmakers Lobby in Bipartisan Push for MDMA Therapy
More than a half century after federal regulators banned most psychedelic compounds, the Food and Drug Administration is nearing a decision on a novel treatment for post-traumatic stress disorder that pairs talk therapy with MDMA.
- 7.16.2024
- News
Press Release: VETS Applauds California Legislature for Expediting Passage of Bill to Resume Psychedelic Research
AB 2841, authored by Assemblymember Marie Waldron (R-Escondido) and co-authored by Senators Allen (D-Los Angeles) and Wiener (D-San Francisco), will allow the RAPC, a state advisory board in the California Attorney General’s Office, to meet in closed session to review and approve confidential scientific and medical research proposals involving cannabis, psychedelics, or the treatment of substance use disorders.
- 7.10.2024
- News
The Economist: Mexico has become a testing ground for psychedelic therapies
Many of those turning to psychedelics are former soldiers. Martín Polanco, a doctor who runs The Mission Within near Tijuana, says he has treated 1,000 veterans with ibogaine since 2016 (researchers do not classify ibogaine as a psychedelic, but it provides some of the same effects).
- 7.10.2024
- News
The San Diego Union-Tribune: Michael Smolens: Psychedelic therapy legislation fails again
Key lawmaker says treatment may eventually provide "significant mental health benefits" but suggests the proposal needs more work.